La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Dopamine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopa < Dopamine < Dopamine dérivé  Facettes :

List of bibliographic references indexed by Dopamine

Number of relevant bibliographic references: 210.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000B10 (2014) Sylvia Navailles [France] ; Lea Milan [France] ; Hanane Khalki [France] ; Giuseppe Di Giovanni [Royaume-Uni, Malte] ; Mélanie Lagiere [France] ; Philippe De Deurwaerdere [France]Noradrenergic Terminals Regulate L-DOPA-derived Dopamine Extracellular Levels in a Region-dependent Manner in Parkinsonian Rats
000B14 (2014) N. Daviaud [France] ; E. Garbayo [France, Espagne] ; N. Lautram [France] ; F. Franconi [France] ; L. Lemaire [France] ; M. Perez-Pinzon [États-Unis] ; C. N. Montero-Menei [France]MODELING NIGROSTRIATAL DEGENERATION IN ORGANOTYPIC CULTURES, A NEW EX VIVO MODEL OF PARKINSON'S DISEASE
000B15 (2014) G. Drui [France] ; S. Carnicella [France] ; C. Carcenac [France] ; M. Favier [France] ; A. Bertrand [France] ; S. Boulet [France] ; M. Savasta [France]Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease
000B22 (2014) M. Morales [États-Unis] ; D. H. Root [États-Unis]GLUTAMATE NEURONS WITHIN THE MIDBRAIN DOPAMINE REGIONS
000B28 (2014) J. Mendoza [France] ; E. Challet [France]CIRCADIAN INSIGHTS INTO DOPAMINE MECHANISMS
000F27 (2013) V. Phe [France] ; R. Caremel [France] ; S. Bart [France] ; E. Castel-Lacanal [France] ; M. De Seze [France] ; F. Duchene [France] ; A. Even [France] ; X. Game [France] ; M. Loubat [France] ; M. C. Scheiber Nogueira [France] ; G. Karsenty [France]Troubles vésicosphinctériens des syndromes parkinsoniens: une revue du comité de neuro-urologie de l'Association française d'urologie
000F48 (2013) Julie Peron [Suisse] ; Sascha Frühholz [Suisse] ; Marc Verin [France] ; Didier Grandjean [Suisse]Subthalamic nucleus: A key structure for emotional component synchronization in humans
000F61 (2013) P. De Deurwaerdère [France] ; M. Lagière [France] ; M. Bosc [France] ; S. Navailles [France]Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology
000F67 (2013) P. M. Abedi [France, Maroc] ; C. Delaville [France] ; P. De Deurwaerdere [France] ; W. Benjelloun [Maroc] ; A. Benazzouz [France]INTRAPALLIDAL ADMINISTRATION OF 6-HYDROXYDOPAMINE MIMICS IN LARGE PART THE ELECTROPHYSIOLOGICAL AND BEHAVIORAL CONSEQUENCES OF MAJOR DOPAMINE DEPLETION IN THE RAT
000F78 (2013) A. Laux-Biehlmann [France] ; J. Mouheiche [France] ; J. Veriepe [France] ; Y. Goumon [France]ENDOGENOUS MORPHINE AND ITS METABOLITES IN MAMMALS: HISTORY, SYNTHESIS, LOCALIZATION AND PERSPECTIVES
000F83 (2013) M. Jaber [France] ; M. Benoit-Marand [France] ; L. Prestoz [France] ; A. Gaillard [France]Cell transplantation in the damaged adult brain
001258 (2012) Nicolas Aznavour [France] ; Christophe Cendres-Bozzi [France] ; Laetitia Lemoine [France] ; Colette Buda [France] ; Jean-Pierre Sastre [France] ; Zoïa Mincheva [France] ; Luc Zimmer [France] ; Jian-Sheng Lin [France]MPTP Animal Model of Parkinsonism: Dopamine Cell Death or Only Tyrosine Hydroxylase Impairment? – A Study Using PET Imaging, Autoradiography, and Immunohistochemistry in the Cat
001322 (2012) Sophie Schumm [France] ; Claude Sebban [France] ; Charles Cohen-Salmon [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Jean-Louis Golmard [France] ; Lydie Boussicault [France] ; Isabelle Petropoulos [France] ; Audrey Hild [France] ; Estelle Rousselet [France] ; Annick Prigent [France] ; Bertrand Friguet [France] ; Jean Mariani [France] ; Etienne C. Hirsch [France]Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
001340 (2012) T. Dondaine [France] ; J. Peron [France, Suisse]Émotion et noyaux gris centraux (I): que peut nous apprendre la maladie de Parkinson ?
001373 (2012) Etienne C. Hirsch [France]Futures pistes thérapeutiques médicamenteuses pour la maladie de Parkinson
001389 (2012) P. De Deurwaerdere [France] ; S. Navailles [France]What can we expect from the serotonergic side of L-DOPA?
001392 (2012) Laurie Mondillon [France] ; Martial Mermillod [France] ; Serban C. Musca [France] ; Isabelle Rieu [France] ; Tiphaine Vidal [France] ; Patrick Chambres [France] ; Catherine Auxiette [France] ; Helene Dalens [France] ; Louise Marie Coulangeon [France] ; Isabelle Jalenques [France] ; Jean-Jacques Lemaire [France] ; Miguel Ulla [France] ; Philippe Derost [France] ; Ana Marques [France] ; Franck Durif [France]The combined effect of subthalamic nuclei deep brain stimulation and L-dopa increases emotion recognition in Parkinson's disease
001395 (2012) Eugenie Lhommee [France] ; Hélène Klinger [France] ; Stéphane Thobois [France] ; Emmanuelle Sch Mitt [France] ; Claire Ardouin [France] ; Amélie Bichon [France] ; Andrea Kistner [France] ; Valérie Fraix [France] ; JING XIE [France] ; Magaly Aya Kombo [France] ; Stephan Chabardes [France] ; Eric Seigneuret [France] ; Alim-Louis Benabid [France] ; Patrick Mertens [France] ; Gustavo Polo [France] ; Sebastien Carnicella [France] ; Jean-Louis Quesada [France] ; Jean-Luc Bosson [France] ; Emmanuel Broussolle [France] ; Pierre Pollak [France] ; Paul Krack [France]Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours
001419 (2012) Eloi Magnin [France] ; Marie Vidailhet [France] ; Ilham Ryff [France] ; Sabrina Ferreira [France] ; Pierre Labauge [France] ; Lucien Rumbach [France]Fronto-striatal dysfunction in type 3 familial cortical myoclonic tremor epilepsy occurring during aging
001427 (2012) Asha Kishore [Inde] ; Thomas Joseph [Inde] ; Balu Velayudhan [Inde] ; Traian Popa [France] ; Sabine Meunier [France]Early, severe and bilateral loss of LTP and LTD-like plasticity in motor cortex (M1) in de novo Parkinson's disease
001429 (2012) C. Delaville [France] ; S. Navailles [France] ; A. Benazzouz [France]EFFECTS OF NORADRENALINE AND SEROTONIN DEPLETIONS ON THE NEURONAL ACTIVITY OF GLOBUS PALLIDUS AND SUBSTANTIA NIGRA PARS RETICULATA IN EXPERIMENTAL PARKINSONISM

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Dopamine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Dopamine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024